Lipid nanoparticles with minimum burst release of TNF-α siRNA show strong activity against rheumatoid arthritis unresponsive to methotrexate

Certolizumab Pegol for the Treatment of Crohn's Disease

William J. Sandborn, Brian G. Feagan, S Stoĭnov et al. · New England Journal of Medicine · 2007 · 1.1K citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +17

Safety analyses of adalimumab (HUMIRA) in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritis

M. Schiff · Annals of the Rheumatic Diseases · 2006 · 393 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +17

Chitosan/siRNA Nanoparticle–mediated TNF-α Knockdown in Peritoneal Macrophages for Anti-inflammatory Treatment in a Murine Arthritis Model

Kenneth A. Howard, Søren R. Paludan, Mark A. Behlke et al. · Molecular Therapy · 2008 · 297 citations · Full text

Life Sciences, Immunology, Molecular Pharmaceutics +17

Animal models, rheumatoid arthritis

A.M. Bendele · SpringerReference · 2011 · 297 citations

Medicine, Immunology, Pharmacology +17

The Effect of Chemical Modification and Nanoparticle Formulation on Stability and Biodistribution of siRNA in Mice

Shan Gao, Frederik Dagnæs‐Hansen, Ebbe Juel Bech Nielsen et al. · Molecular Therapy · 2009 · 290 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17